Story
Natera Stock Hits 52-Week High on Record Signatera Test Volumes

Natera Inc. (NASDAQ:NTRA) shares reached a new 52-week high this week, propelled by company disclosures of record demand and accelerating momentum for its flagship Signatera cancer-monitoring test.
Signatera Growth Accelerates
Speaking at the 2026 Global Healthcare Conference on September 16, Natera executives revealed that sequential unit additions for Signatera hit approximately 34,000. This figure significantly surpasses the company's previous record of 25,000 set in the first quarter, signaling accelerating adoption of the test.
The company also reported a steady increase in the average selling price (ASP), which has climbed by $25 for three consecutive quarters to reach about $1,275 per test. Management reiterated its long-term ASP target of $2,000 and maintained its full-year revenue guidance with a midpoint around $2.9 billion.
AdMarket Performance and Analyst Views
The positive operational update pushed Natera's stock to a fresh 52-week high of $347.10 before closing at $345.34 on September 17. The rally has lifted the company's market capitalization to nearly $49.2 billion.
This performance builds on a strong prior quarter in which Natera's revenue grew 37.7% year-over-year to $752.8 million. In response to the growth story, Guggenheim raised its price target to $360 with a Buy rating. The broader analyst consensus target of approximately $330.83 now sits below the stock's current trading level, indicating that recent price action has outpaced some market expectations.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.